Beyond Medical Announces Director Change
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) has announced a change in its board of directors. Hongming Luo has been appointed as a new director, bringing expertise in AI, Blockchain, Healthcare Tech, and derivatives markets. This appointment follows the resignation of Harveer Sidhu, effective February 4, 2025.
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) ha annunciato un cambiamento nel consiglio di amministrazione. Hongming Luo è stato nominato nuovo direttore, portando con sé esperienze in AI, Blockchain, tecnologia sanitaria e mercati dei derivati. Questa nomina segue le dimissioni di Harveer Sidhu, effettive dal 4 febbraio 2025.
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) ha anunciado un cambio en su junta directiva. Hongming Luo ha sido nombrado nuevo director, aportando experiencia en IA, Blockchain, tecnología sanitaria y mercados de derivados. Este nombramiento sigue a la renuncia de Harveer Sidhu, efectiva el 4 de febrero de 2025.
비욘드 메디컬 테크놀로지스 (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF)가 이사회의 변화를 발표했습니다. 홍밍 로우가 새로운 이사로 임명되어 AI, 블록체인, 헬스케어 기술 및 파생 상품 시장에 대한 전문성을 가져옵니다. 이번 임명은 2025년 2월 4일부로 유효한 하르비르 시두의 사임 후 이루어졌습니다.
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) a annoncé un changement dans son conseil d'administration. Hongming Luo a été nommé nouveau directeur, apportant son expertise en IA, blockchain, technologie de la santé et marchés des dérivés. Cette nomination fait suite à la démission de Harveer Sidhu, effective le 4 février 2025.
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) hat eine Änderung im Vorstand bekannt gegeben. Hongming Luo wurde als neuer Direktor ernannt und bringt Fachkenntnisse in den Bereichen KI, Blockchain, Gesundheitstechnologie und Derivatemärkte mit. Diese Ernennung folgt auf den Rücktritt von Harveer Sidhu, der am 4. Februar 2025 wirksam wird.
- Appointment of new director with expertise in AI, Blockchain, and Healthcare Tech sectors
- None.
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce that it has appointed Hongming Luo as a director of the Company. Mr. Luo brings extensive experience in the technology sector, namely focusing on AI, Blockchain and Healthcare Tech, as well as the derivatives markets. Mr. Luo replaces Harveer Sidhu, who has resigned as a director, effective February 4, 2025. The Company would like to thank Mr. Sidhu for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
"Daniel Liu" Chief Executive Officer
Email: daniel@republictechs.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239697
FAQ
Who is the new director appointed to Beyond Medical Technologies (DOCKF) in February 2025?
Which director resigned from Beyond Medical Technologies (DOCKF) in February 2025?
What expertise does the new Beyond Medical Technologies (DOCKF) director bring to the board?
When did the director change at Beyond Medical Technologies (DOCKF) take effect?
